Search

MAKING SENSE OF PRES. BIDEN’S CANNABIS REFORM STATEMENT – FDA’S ROLE IN SCHEDULING EVALUATION Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will discuss President Biden’s recent cannabis reform announcement, its implications for various stakeholders, and FDA’s role in evaluating how...

Jonathan Havens, co-chair of the Firm's Cannabis Law Practice and Food, Beverage and Agribusiness Practice, will speak at the Food and Drug Law Institute’s Annual Conference as a panelist during the session on “Preparing for Federal Legalization of Cannabis: Lessons Learned from Other Industries.”...